Therapeutic Potential of Rho-Kinase Inhibitors in Cardiovascular Diseases

Author： Hirooka Yoshitaka Shimokawa Hiroaki

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.5, Iss.1, 2005-01, pp. : 31-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges

By Hu Erding Lee Dennis

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 715-736

Informa Healthcare

Access to resources Recommend Favorite

Rho-kinase inhibitors show promise in pulmonary hypertension

By Doggrell Sheila A

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 9, 2005-09 ,pp. : 1157-1159

Informa Healthcare

Access to resources Recommend Favorite

p38 MAP Kinase Inhibitors as Potential Therapeutic Drugs for Neural Diseases

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 1, 2011-03 ,pp. : 45-59

Bentham Science Publishers

Access to resources Recommend Favorite

Rho-kinase inhibitors offer a new approach in the treatment of glaucoma

By Challa Pratap Arnold John J

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 81-95

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases

By Chopra Puneet Kanoje Vijay Semwal Arvind Ray Abhijit

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 10, 2008-10 ,pp. : 1411-1425

Informa Healthcare

Access to resources Recommend Favorite